Climb Bio, Inc. (CLYM)
10.94
-0.13
(-1.17%)
USD |
NASDAQ |
Oct 02, 16:00
11.10
+0.16
(+1.46%)
Pre-Market: 08:58
Climb Bio Price to Book Value : 2.623 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.623 |
| October 01, 2026 | 2.654 |
| September 30, 2026 | 2.750 |
| September 29, 2026 | 2.757 |
| September 28, 2026 | 2.815 |
| September 25, 2026 | 2.796 |
| September 24, 2026 | 2.851 |
| September 23, 2026 | 3.002 |
| September 22, 2026 | 3.407 |
| September 21, 2026 | 3.270 |
| September 18, 2026 | 3.369 |
| September 17, 2026 | 3.371 |
| September 16, 2026 | 3.383 |
| September 15, 2026 | 3.335 |
| September 14, 2026 | 3.491 |
| September 11, 2026 | 3.417 |
| September 10, 2026 | 3.585 |
| September 09, 2026 | 3.608 |
| September 08, 2026 | 3.812 |
| September 04, 2026 | 3.721 |
| September 03, 2026 | 3.498 |
| September 02, 2026 | 3.608 |
| September 01, 2026 | 3.553 |
| August 31, 2026 | 3.292 |
| August 28, 2026 | 3.494 |
| Date | Value |
|---|---|
| August 27, 2026 | 3.611 |
| August 26, 2026 | 3.856 |
| August 25, 2026 | 4.278 |
| August 24, 2026 | 3.932 |
| August 21, 2026 | 4.143 |
| August 20, 2026 | 4.081 |
| August 19, 2026 | 4.158 |
| August 18, 2026 | 4.170 |
| August 17, 2026 | 4.182 |
| August 14, 2026 | 3.916 |
| August 13, 2026 | 3.532 |
| August 12, 2026 | 3.450 |
| August 11, 2026 | 3.321 |
| August 10, 2026 | 3.246 |
| August 07, 2026 | 3.357 |
| August 06, 2026 | 3.357 |
| August 05, 2026 | 2.990 |
| August 04, 2026 | 3.012 |
| August 03, 2026 | 2.832 |
| July 31, 2026 | 2.853 |
| July 30, 2026 | 2.896 |
| July 29, 2026 | 2.904 |
| July 28, 2026 | 2.947 |
| July 27, 2026 | 3.067 |
| July 24, 2026 | 3.079 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Korsana Biosciences, Inc. | 3.644 |
| Cullinan Therapeutics, Inc. | 3.112 |
| Q32 Bio, Inc. | 1.845 |
| Artiva Biotherapeutics, Inc. | 0.959 |
| Arrowhead Pharmaceuticals, Inc. | 19.46 |
Price to Book Value Related Metrics
| PEG Ratio | -0.6849 |
| Price | 10.94 |
| Earnings Yield | -7.57% |
| Market Cap | 628.35M |
| PEGY Ratio | -0.6849 |